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Anemia is a common morbidity seen among neonates admitted to intensive care units. Frequent blood sampling is often required for repeated monitoring of various 
blood parameters to measure the extent of multiorgan dysfunction 
and response to the treatment [1,2]. The most common cause of 
anemia reported in sick neonates is iatrogenic due to frequent 
blood sampling [1]. Venous sampling is associated with various 
drawbacks such as invasiveness, pain, discomfort, risk of hospital-
acquired infections, and need of transport to laboratory for 
processing which further delays the process of diagnosing and 
planning interventions [3]. This iatrogenic anemia often results in 
need of blood transfusions. Among the various methods known to 
reduce iatrogenic anemia, point of care devices such as glucometers 
and transcutaneous bilirubinometers is found to play a major 
role [1,4]. The gold standard for hemoglobin estimation is venous 
hemoglobin measured by automated hematology analyzer [5]. 
A non-invasive method has been developed for rapid point of 
care estimation of hemoglobin using pulse co-oximeter. Pulse 
co-oximeters measure hemoglobin non-invasively using multiple 
wavelength spectrophotometry technology [6]. Few studies in 
the past have attempted validating transcutaneous hemoglobin in 
stable neonates, but studies are very limited in sick babies. With 
this background, we conducted a study to compare non-invasive 
hemoglobin measured by Masimo radical 7 pulse co-oximeter with 
invasive venous hemoglobin estimated by automated hematology 
analyzer in neonates admitted to a tertiary level neonatal care unit.
MATERIALS AND METHODS
We conducted this prospective observational study at a tertiary 
care neonatal unit in Chennai, South India, from November 2016 
to December 2016. After getting institutional ethical committee 
approval, we included all babies who needed hemoglobin estimation 
as warranted by management protocol during the study period 
irrespective of their birth weight, gestational age, postnatal age, 
or sickness level. After obtaining informed written consent from 
parents, demographic characteristics of included babies such as 
birth weight, gestational age, sex, and postnatal age were recorded.
Clinical parameters such as heart rate, saturation, capillary 
filling time, blood pressure, saturation, and the level of 
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respiratory and ionotropic support were noted. The newborns 
with tachycardia, temperature instability, prolonged capillary 
refill time, and oliguria with or without hypotension were 
categorized as having shock. The transcutaneous hemoglobin 
was estimated by attaching the probe of the Masimo Radical 7 
co-oximeter adhesive sensor (R1 20L) to one thumb, and it was 
shielded from light by covering it with ambient shield as per the 
manufacturer’s specifications. If hemoglobin was not picked 
up even at 10 min, then the site of assessment was changed to 
another thumb or great toe. If we could not pick up a signal 
from both the sites, we categorized it as device failure. Venous 
hemoglobin was estimated by taking 1 ml of blood in the EDTA 
tube and analyzing at central laboratory by Sysmex automated 
hematology analyzer. Laboratory technicians who estimated 
invasive venous hemoglobin were blinded about transcutaneous 
hemoglobin measurement. We labeled neonates as anemic, if 
invasive hemoglobin was <13 g/dl as per the WHO definition [7]. 
In a previous study, the reported intraclass correlation coefficient 
(ICC) was 0.94 between invasive and transcutaneous hemoglobin 
[8,9]. With confidence set at 95% and precision of 0.04, the 
required sample size was 132 babies.
Statistical Methods
We summarized continuous variables as mean and standard 
deviation if the variables are normally distributed and as median and 
interquartile range (IQR) if the distribution was skewed. Bland–
Altman plot was used for graphical presentation of agreement 
between the two measurements. The mean of transcutaneous 
and venous hemoglobin was plotted on x-axis and the difference 
between these two values was plotted on y-axis. A horizontal line 
was drawn to represent the bias. The 95% confidence interval 
indicated the limits of agreement (LOA) between these values. 
The degree of agreement was further confirmed by estimating 
ICC [10]. Univariate and multivariate regression analysis were 
done to study the factors influencing bias and device failure.
RESULTS
Of 158 newborns enrolled, transcutaneous hemoglobin was not 
picked up by pulse co-oximeter in 20 babies. Hence, the device 
failure rate was 12.6%. Clinical characteristics of the babies are 
presented in Table 1. Median (IQR) gestational age was 36 (32 
and 38) weeks and median (IQR) birth weight was 2190 (1175 
and 2790) g. Median (IQR) postnatal age was 10 (4 and 16) days. 
61.5% of our study population were male and 29.5% were female. 
30% of babies required ventilation during the study period. The 
mean transcutaneous hemoglobin was 14.22±2.3 g/dl, whereas 
the mean venous hemoglobin was 12.24±3.13 g/dl.
55% of babies had hemoglobin level <13 g/dl by invasive 
method. Transcutaneous hemoglobin was not picked up in 17.2% 
of babies with hemoglobin level <13 g/dl and in 26.4% of babies 
with hemoglobin <10 g/dl. 13.2% of babies had shock requiring 
inotropes. Transcutaneous hemoglobin was not picked up in 33.3% 
of  babies with shock. Furthermore, factors influencing the device 
failure rate were analyzed by regression analysis. Although perfusion 
index, shock, and level of hemoglobin were found to influence 
the device failure rate in univariate analysis, only the level of 
hemoglobin influenced device failure significantly on a multivariate 
model (Table 2). The overall bias between transcutaneous and 
venous hemoglobin was 1.66±2.26 g/dl (Fig. 1), and the values 
showed moderate agreement with ICC of 0.56. In babies with 
anemia (<13 g/dl), the bias was 2.69±1.87, which was significantly 
higher than the bias of 0.54±2.11 in babies with hemoglobin >13 g/dl 
(Fig. 2). Both the values showed poor agreement with ICC of 0.284.
As blood transfusion usually would be required at lower 
hemoglobin levels (<10 g/dl), the agreement was estimated at 
venous hemoglobin level of ≤10 g/dl. Bias was 3.29±1.86 showing 
poor agreement with an ICC of 0.10 (Fig. 3). Bias between both 
the measurements in babies with shock was 2.04±3.23 g/dl, 
whereas in babies without shock, it was 1.62±2.13 g/dl. Factors 
influencing the bias were analyzed using regression methods. In 
univariate analysis, only the level of hemoglobin significantly 
influenced the bias (Table 3).
DISCUSSION
The transcutaneous hemoglobin estimation by pulse co-oximeter 
device has made difference in the decision-making and hemodynamic 
monitoring in adult ICUs and surgical units. Application of this tool 
Table 1: Baseline characteristics
Variables Median (IQR) (n=158)
Birth weight (g) 2190 (1175, 2790)
Gestational age (weeks) 36 (32, 38)
Perfusion index 0.9 (0.7, 1.2)
Saturation (%) 96 (94, 98)
Postnatal age (days) 10 (4, 16)
Heart rate (beats/min)* 149.20 (17.24)
Venous hemoglobin (g/dl)* 12.24 (3.13)
Transcutaneous hemoglobin (g/dl)* 14.22 (2.36)
*Values are represented as mean (SD). IQR: Interquartile range, SD: Standard 
deviation
Table 2: Analysis of factors associated with device failure
Variable Odds ratio 95% CI р value
Univariate analysis
Gestational age (weeks) 1.06 0.93, 1.19 0.39
Birth weight (g) 0.68  0.07, 6.64 0.74
Heart rate (beats/min) 1.00 0.98, 1.03 0.78
Perfusion index 0.29 0.09, 0.98 0.05
Saturation (%) 0.99 0.86, 1.14 0.87
Shock (Y/N) 0.27 0.09, 0.81 0.02
Hemoglobin (g/dl) 0.81 0.68, 0.96 0.01
Multivariate analysis
Perfusion index 0.35 0.10, 1.22 0.10
Shock (Y/N) 0.34 0.11, 1.12 0.08
Hemoglobin (g/dl) 0.83 0.70, 0.98 0.03
CI: Confidence interval
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in clinical decision-making is being evaluated in neonates admitted 
to the NICU. In our study, there was only moderate agreement 
between venous and transcutaneous hemoglobin (ICC=0.56). 
The LOA were wide apart. Our bias (1.66±2.26) was more when 
compared to that in the study by Nicholas et al. (−0.09±1.67 g/
dl) [11]. Bhat et al. studied healthy and sick children and reported 
an excellent positive correlation between the measurements [8]. 
However, their LOA were also wide apart similar to our study. 
In our study, we found the bias between the measurements to be 
higher at lower levels of hemoglobin when compared to babies 
with normal levels of hemoglobin. We analyzed the various factors 
which could influence the bias between these measurements such 
as gestational age, weight, saturation, perfusion index, heart rate, 
and the level of hemoglobin. Only the level of hemoglobin was 
found to have statistically significant influence independently 
on the mean difference. The greater bias in our study could be 
due to more number of babies with lower levels of hemoglobin 
in our study. However, in the study by Aditya et al., the bias was 
significantly higher in babies with shock as compared to healthy 
ones (−2.31±2.21 vs. −0.77±1.2 g/dl). However, in our study, shock 
was not found to influence the bias. This could be due to small 
numbers of babies with circulatory dysfunction in our study.
Gayat et al. also found that the bias was influenced by true 
hemoglobin levels and the oxygen saturation of the patient [12]. In 
a study by Khalafallah et al. for screening in pre-operative patients, 
the differences between both venous and transcutaneous hemoglobin 
appeared to be even across the range of hemoglobin values [13]. In 
a study conducted by Vora and Desai in neonates, the average bias 
was −0.2 with hemoglobin <12 and −0.1 at hemoglobin >12 [14]. 
In a study by Jung et al., the laboratory hemoglobin correlated well 
with transcutaneous hemoglobin at levels <18 g/dl. At hemoglobin 
levels >18 g/dl, the correlation was not good [15]. Since blood 
transfusion would be required at lower hemoglobin levels (<10 g/
dl), there should be good agreement, but the weak agreement in our 
study could limit its utilization for deciding on blood transfusion.
In our study of 158 newborn babies, the device failure rate 
was 12.6%. Among the various factors which could influence the 
pickup rate such as gestational age, weight, heart rate, saturation, 
perfusion index and shock, the level of hemoglobin, and 
perfusion index, and shock showed significant association with 
device failure rate on univariate analysis. However, on regression 
analysis, only the level of hemoglobin was found to influence the 
device failure rate significantly. Previous studies by Jung et al. 
and Bhat et al. have documented device failure rate of 1.3% 
and 17%, respectively [8,15]. The adhesive sensor supplied by 
the Masimo SET rainbow (R1 20L) sensor for infant’s weighing 
between 3 and 10 kg is used in all the studies due to the non-
availability of an appropriate sensor for babies <3 kg.
CONCLUSION
Non-invasive hemoglobin measured by pulse co-oximeter shows 
only a moderate agreement with reference venous hemoglobin 
in neonates admitted to nursery. We report a high device failure 
rate of 12.6%. Level of hemoglobin is the single most important 
Table 3: Univariate analysis for factors influencing the bias 
between non-invasive and invasive hemoglobin
Variable Regression 
coefficient
95% CI р value
Gestational age (weeks) 0.06 −0.03, 0.15 0.20
Birth weight (g) −0.13 −0.81, 0.55 0.70
Heart rate (beats/min) 0 −0.02, 0.02 0.78
Perfusion index 0.06 −0.62, 0.73 0.87
Saturation (%) −0.03 −0.14, 0.08 0.57
Shock (Y/N) −0.41 −1.67, 0.85 0.52
Level of hemoglobin (g/dl) −0.47 −0.57, −0.38 <0.001
CI: Confidence interval
Figure 1: Bland–Altman plot between non-invasive and venous 
hemoglobin (n=138)
Figure 2: Bland–Altman plot between non-invasive and venous 
hemoglobin at hemoglobin level <13 g/dl (n=72)
Figure 3: Bland–Altman plot between transcutaneous and venous 
hemoglobin at hemoglobin level ≤10 (n=34)
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determinant of device failure and degree of agreement. With a 
high device failure rate and poor agreement at low hemoglobin 
levels, the clinical utility appears negligible. Further, research 
should focus on developing better devices or technology to apply 
this much-needed tool in neonatal intensive care units.
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